Tracking Medicare news, policy, and coverage changes.
An OIG report found that the three largest Medicare Advantage insurers denied prior authorization requests for long-term acute care and inpatient rehabilitation at higher rates than other MA plans in 2024. The post OIG: 3 Largest MA Insurers Deny Prior Auth Requests at High Rates for Long-Term Acute Care, Inpatient Rehab appeared first on MedCity News .
Read full article →FDA concerns about Amgen’s Tavneos were sparked by securities fraud litigation against ChemoCentryx, the company that originally developed the rare disease drug. The FDA wants to withdraw Tavneos’s approval, citing safety risks and alleged manipulation of the drug’s clinical trial data. The post Amgen Turns to an Independent Review to Defend Rare Disease Drug in FDA Crosshairs appeared first on MedCity News .
Read full article →The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and BJC Health, much of that investment could be wasted. During a panel this week at HFMA’s annual conference, they argued that no amount of sophisticated tech can overcome a broken, antiquated data foundation. The post Bot vs. Bot: Why Healthcare AI Progress Might Be Stuck appeared first on MedCity News .
Read full article →Trump administration revisits policy to plug Medicare drug price negotiation loophole.
Read full article →(MedPage Today) -- A 2010 paper that linked hepatitis B vaccines in infant boys to an increased risk of autism diagnosis was retracted and another study by the same authors is under investigation. The study, published in the Journal of Toxicology...
Read full article →(MedPage Today) -- Alcohol consumption during pregnancy has been on the rise in recent years, with some groups, like unmarried women and women in frequent distress, more likely to partake, CDC data showed. Responding to a survey, 15.2% of pregnant...
Read full article →(MedPage Today) -- The FDA approved capivasertib (Truqap) in combination with abiraterone (Zytiga) and prednisone for PTEN-deficient prostate cancer, the agency announced on Friday. Approval stipulates use in metastatic hormone-sensitive prostate...
Read full article →(MedPage Today) -- The FDA on Friday approved belzutifan (Welireg) plus pembrolizumab (Keytruda, Keytruda Qlex) as adjuvant therapy for renal cell carcinoma (RCC) with a clear cell component. Based on results from LITESPARK-022, the combination...
Read full article →(MedPage Today) -- Several top pro athletes and their surgeons say a modern version of an old tool is shaving weeks off the recovery time for certain injuries. And some top doctors think this is only the beginning. Cy Young Award winners Tarik...
Read full article →(MedPage Today) -- Firefighters responding to a blaze that destroyed a massive medical equipment warehouse in Northern California and sent embers flying for miles were hindered by sprinklers and hydrants that weren't working, authorities said Friday...
Read full article →(MedPage Today) -- Scammers used the identity of Brian Druker, MD, the renowned leukemia researcher known for his work developing imatinib (Gleevec), to pitch ivermectin as a cancer cure. (OregonLive) A phase III trial involving lurbinectedin...
Read full article →The tentative deal comes months after CVS Health reached a proposed settlement in the lawsuit alleging major pharmacy benefit managers are inflating insulin costs.
Read full article →